Article
Molecular testing for cytologically suspicious and malignant (Bethesda V and VI) thyroid nodules to optimize the extent of surgical intervention: a retrospective chart review.
Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale - 28 Apr 2021
Hier Jessica, Avior Galit, Pusztaszeri Marc, Krasner Joshua R, Alyouha Noura, Forest Veronique-Isabelle, Hier Michael P, Mlynarek Alex, Richardson Keith, Sadeghi Nader, Tamilia Michael, Payne Richard J
Abstract excerpt
BACKGROUND: Molecular testing has been used for cytologically indeterminate thyroid nodules (Bethesda III and IV), where the risk of malignancy is 10-40%. However, to date, the role of molecular testing in cytologically suspicious or positive for malignancy (Bethesda V and VI) thyroid nodules has been controversial. The aim of this study was to determine whether patients who had molecular testing in Bethesda V...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.